Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
| Conditions: | Lung Cancer|Malignant Mesothelioma|Metastatic Cancer|Thymoma and Thymic Carcinoma |
| Start Date: | July 1, 2001 |
| Phase: | Phase II |
| Status: | Active, not recruiting |
| NCT ID: | NCT00024076 |
| Study Type: | Interventional |
| Intervention: | Procedure: radiofrequency ablation |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | University of California, Los Angeles|National Cancer Institute (NCI) |
| Ages: | Child|Adult|Senior |
| Enrollment: | 0 |
| Funded By: | Other|NIH |
| First Received: | September 13, 2001 |
| End Date: | |
| Last Updated: | July 21, 2010 |
| Last Verified: | July 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
